341 related articles for article (PubMed ID: 11287562)
21. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
22. Production of Retrovirus-Based Vectors in Mildly Acidic pH Conditions.
Holic N; Fenard D
Methods Mol Biol; 2016; 1448():41-8. PubMed ID: 27317171
[TBL] [Abstract][Full Text] [Related]
23. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
24. Episodic Diversifying Selection Shaped the Genomes of Gibbon Ape Leukemia Virus and Related Gammaretroviruses.
Alfano N; Kolokotronis SO; Tsangaras K; Roca AL; Xu W; Eiden MV; Greenwood AD
J Virol; 2016 Feb; 90(4):1757-72. PubMed ID: 26637454
[TBL] [Abstract][Full Text] [Related]
25. A vector system for introducing foreign HIV-1 env genes and pseudotyping of MuLV particles with the recombinant HIV-1 envelope proteins for anti-HIV-1 assay.
Lee MK; Seo JK; Kim HK; Cho JH; Poo H; Kim KL
Antiviral Res; 2002 Feb; 53(2):99-111. PubMed ID: 11750936
[TBL] [Abstract][Full Text] [Related]
26. Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism.
Bruett L; Clements JE
J Virol; 2001 Dec; 75(23):11464-73. PubMed ID: 11689628
[TBL] [Abstract][Full Text] [Related]
27. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
Yang C; Compans RW
J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533
[TBL] [Abstract][Full Text] [Related]
29. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.
Sakuma T; De Ravin SS; Tonne JM; Thatava T; Ohmine S; Takeuchi Y; Malech HL; Ikeda Y
Hum Gene Ther; 2010 Dec; 21(12):1665-73. PubMed ID: 20507233
[TBL] [Abstract][Full Text] [Related]
30. Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.
Logg CR; Baranick BT; Lemp NA; Kasahara N
J Mol Biol; 2007 Jun; 369(5):1214-29. PubMed ID: 17498744
[TBL] [Abstract][Full Text] [Related]
31. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells.
Bunnell BA; Kluge KA; Lee-Lin SQ; Byrne ER; Orlic D; Metzger ME; Agricola BA; Wersto RP; Bodine DM; Morgan RA; Donahue RE
Gene Ther; 1999 Jan; 6(1):48-56. PubMed ID: 10341875
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide.
Aguilar HC; Anderson WF; Cannon PM
J Virol; 2003 Jan; 77(2):1281-91. PubMed ID: 12502845
[TBL] [Abstract][Full Text] [Related]
35. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
36. Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells.
Relander T; Johansson M; Olsson K; Ikeda Y; Takeuchi Y; Collins M; Richter J
Mol Ther; 2005 Mar; 11(3):452-9. PubMed ID: 15727942
[TBL] [Abstract][Full Text] [Related]
37. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
38. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
[TBL] [Abstract][Full Text] [Related]
39. Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.
Radek C; Bernadin O; Drechsel K; Cordes N; Pfeifer R; Sträßer P; Mormin M; Gutierrez-Guerrero A; Cosset FL; Kaiser AD; Schaser T; Galy A; Verhoeyen E; Johnston ICD
Hum Gene Ther; 2019 Dec; 30(12):1477-1493. PubMed ID: 31578886
[TBL] [Abstract][Full Text] [Related]
40. Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype.
Uckert W; Becker C; Gladow M; Klein D; Kammertoens T; Pedersen L; Blankenstein T
Hum Gene Ther; 2000 May; 11(7):1005-14. PubMed ID: 10811229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
